Kevin Guest - 19 Feb 2026 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)

Role
CEO & EXEC. CHAIRMAN OF BOARD
Signature
/s/ Joshua Foukas, Attorney-in-Fact
Issuer symbol
USNA
Transactions as of
19 Feb 2026
Net transactions value
$0
Form type
4
Filing time
23 Feb 2026, 18:17:22 UTC
Previous filing
10 Feb 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Guest Kevin CEO & EXEC. CHAIRMAN OF BOARD 3838 WEST PARKWAY BLVD, SALT LAKE CITY /s/ Joshua Foukas, Attorney-in-Fact 23 Feb 2026 0001353496

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction USNA Restricted Stock Units Award $0 +82,726 +158% $0.000000 135,062 19 Feb 2026 Common Stock 82,726 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
F2 On February 19th 2026, the reporting person was granted restricted stock units, vesting at 25% on each 19th of February thereafter.